with gradual dilatation of the cystic duct and migration of stones from the gall bladder.3
There are several clinical implications. The long contiguous course of the cystic duct and common hepatic duct could explain why surgeons sometimes inadvertently leave a long remnant of cystic duct, which is reputedly a cause of the postcholecystectomy syndrome.4 Furthermore, the migration of stones from the gall bladder into the contiguous segment may explain transient episodes of jaundice and, with more severe impaction of stones, cause persistent obstructive jaundice, the so called Mirizzi syndrome.
We thank Mrs H P Essel for her help. The study was supported by the South African Medical Research Council and the Staff Research Fund, University of Cape Town. Glyceryl trinitrate has been used to treat angina pectoris for many years, yet no formal studies have established patients' understanding of its use. We showed that an information booklet can educate patients about sublingual glyceryl trinitrate,' and we report a study to determine patients' knowledge of this drug.
Patients, methods, and results
We designed a questionnaire to assess inpatients' knowledge of their prescribed glyceryl trinitrate. Questions were included about how glyceryl trinitrate works, dosage, how to take and store it, side effects, and what to do should side effects occur. Fifty patients, 28 men (mean age 62 (SD 11-6) years) and 22 women (mean age 67 4 (12) years), were studied. The mean time of treatment with sublingual glyceryl trinitrate was 5 5 years (range one week to 12 years).
Only one of us (EAK) collected data from the questionnaire. Correct answers scored one point and incorrect or "don't know" responses none. Two questions required multiple answers. A maximum score of six points was awarded for knowing how to take a tablet correctly, one point being given for each of tipping some tablets into the bottle cap, selecting one; sitting down or standing still for a moment; placing one tablet under the tongue; not eating, drinking, or smoking while taking the drug; and replacing the cap of the bottle tightly. A maximum of four points was awarded for side effects, one for each of headache, flushing, dizziness, and burning sensation in the mouth. The correct answer for the drug's dosage was taking a maximum of three tablets in 15 minutes-the second tablet five minutes after the first and the third five minutes after the second-and thereafter seeking medical help if this regimen was ineffective.
Only 15 patients remembered receiving advice about their tablets. Forty seven patients knew the indication for their use. Most called their tablets GTN, and 13 also knew them as either TNT or trinitrin. Six patients understood glyceryl trinitrate's mode of action. Six patients understood the word "sublingual," and 25 knew that these tablets could be used prophylactically. The patients' knowledge of the dosing, storage, and side effects was poor (table).
Comment
Patients showed a depressing lack of knowledge of their drug treatment, and many did not know how to take sublingual glyceryl trinitrate tablets correctly. 32 BMJ VOLUME 297 2 JULY 1988
